SENSEX NIFTY

Cancer Drugs

Oct 31, 2014 at 11:01 | Source: PTI
An international organisation working for cancer affected people has asked the Obama administration not to pressurise India to reject a compulsory license on a drug for a rare form of leukaemia which would be a de facto endorsement of an excessive price.
Sep 04, 2014 at 12:22 | Source: Moneycontrol.com
Venus Remedies has recently entered into a collaborative agreement with TEVA for a block buster Anti Cancer drug.
Aug 27, 2014 at 13:43 | Source: Moneycontrol.com
Venus Remedies will be initially manufacturing the drug at the Venus Medicine Research Centre, its research unit, for assisting Teva in registrations.
Aug 20, 2014 at 13:40 | Source: Moneycontrol.com
"Venus has achieved yet another landmark by receiving its first marketing authorisation in Switzerland from Swiss drug authority (SWISSMEDIC) for Gemcitabine 200 mg and 1 g injection through Venus Pharma GmbH, the German subsidiary," said the company in its filing.
Aug 20, 2014 at 11:29 | Source: Moneycontrol.com
GBR 1302 was discovered and developed by Glenmark Biologics Research Centre located in La Chaux-de-Fonds, Switzerland and would be first molecule to could become a patented molecule or drug for the company once it goes through multiple stages of research and development.
Aug 20, 2014 at 11:23 | Source: CNBC-TV18
GBR 1302 molecule is a genetically engineered molecule and will be used for the study of breast cancer, says Michael Buschle.
Aug 20, 2014 at 10:30 | Source: CNBC-TV18
GBR 1302 was discovered and developed by Glenmark Biologics Research Centre located in La Chaux-de-Fonds, Switzerland and would be first molecule to could become a patented molecule or drug for the company once it goes through multiple stages of research and development.
Aug 06, 2014 at 13:38 | Source: PTI
Sanofi will continue to provide strong scientific and medical support to Emcure's already well-established and fast growing oncology business.
Jul 19, 2014 at 16:08 | Source: Moneycontrol.com
Last week the Bombay High Court upheld the compulsory license granted to Indian pharma company Natco for the sale of a generic version of Bayer's anti-cancer drug Nexavar. Here's a look back at the first legal challenge against a compulsory license in India.
Jul 16, 2014 at 09:01 | Source: Moneycontrol.com
Natco is pleased to inform that the Bombay High Court upheld the compulsory license (CL) granted to the Company on Nexavar (sorafenib tosylate) of German drug Major Bayers patented kidney cancer drug.
Messages on Cancer Drugs »

sanecounsel

Platinum Member

76 Followers

Biocon  

the outcome of the Delhi High Court case brought by Roche against Biocon and Mylan in February gains significance. Roche has alleged that Biocon/Mylan has misrepresented its drugs as a biosimilar of its bestselling breast cancer drug, Trastuzumab (Herceptin), without having undergone the required

10.04 AM Jul 8th

Sun Pharma  

Sun Pharma recalls 200 vials of cancer drug from US market. After seeing this I am sure Marketman will make his appearance on this forum/

7.17 PM Jul 3rd

sahil456

New Member

4 Followers

Just Posted  

Sun Pharma recalls 200 vials of cancer drug - FDA

1.28 PM Jul 3rd

jackson 333

New Member

4 Followers

Aanjaneya Life  

Do not know but its a strong possibility. As per Annual Report posted on this site,Unit 3 is to be an state of the art ultramodern facility for anti-cancer drugs likely to be ready for production by Oct 14. Please verify the news and keep updating.

1.30 PM Jul 1st

marketman

Platinum Member

16500 Followers

Natco Pharma  

.... After that it has been rising with the improved business.... Company is specialised in manufacturing low priced cancer drugs.... Its promoter CEO looks very tall about 6`3".... Yet to give bonus or stock split.....

10.18 AM Jun 30th

Sunn1

New Member

0 Follower

Pfizer  

french biotech cellectis surges as pfizer signs cancer drug deal... source: reuters

1.21 PM Jun 19th

shivangee

Silver Member

10 Followers

Pfizer  

Promising cancer drug data helps AstraZeneca in Pfizer fight

2.01 PM May 16th

shivangee

Silver Member

10 Followers

Just Posted  

Promising cancer drug data helps AstraZeneca in Pfizer fight

1.20 PM May 16th

cjvora

Gold Member

41 Followers

Sun Pharma  

SETTLEMENT WITH NOVARTIS AND LAUNCH CANCER DRUG IN 2016 MAKE THIS STOCK ALL TIME HIGH AT CURRENT TIME.......700 plus in coming days! just hold this gem stock in ur hand......good luck.

12.45 PM May 15th

balvirsingh
123

Gold Member

27 Followers

Aanjaneya Life  

also you will know the position of Mire BV in cancer drug industry in that article.

2.04 PM May 13th

News across the web »
Oct 29, 2014 at 03:42 | Source: BBC
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.